secwatch.observer — SEC 8-K summary
======================================

Issuer:     InspireMD, Inc. (NSPR)
CIK:        0001433607
Form:       8-K
Filed at:   2023-05-15T23:59:59+00:00
Accession:  0001493152-23-017367
Event type: other_material
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

InspireMD announces $42.2M upfront private placement with up to $113.6M total; led by Marshall Wace
--------------------------------------------------------------------------------

- Gross proceeds of $42.2M upfront; additional $71.4M if milestone-driven warrants exercised in cash.
- Investors include Marshall Wace, OrbiMed, Rosalind, Nantahala, Soleus, Velan, and certain board members.
- Warrants exercisable at $1.3827/share upon FDA approvals or pivotal trial results (4 series, each ~$17.9M).
- Net proceeds to fund product/clinical development, regulatory approvals, and U.S. launch of CGuard Prime and SwitchGuard.
- Closing expected May 15, 2023; Piper Sandler, A.G.P., LifeSci Capital act as advisors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1433607/000149315223017367/0001493152-23-017367-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1433607/000149315223017367/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-017367

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer